Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹923.80down ₹22.20 (2.35%)BSE ₹924.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹946.00.
30 Oct: open ₹946.00, high ₹951.80, low ₹920.00
52-week range of traded prices to 30 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,714 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 35.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,22937.1% delivered
Jubilant Pharmova analyst meets
85 filed, newest first. Page 1 of 2.
Aug 2026
5 Aug · Analysts
May 2026
22 May · Analysts
21 May · Analysts
18 May · Analysts
Apr 2026
24 Apr · Analysts
24 Apr · Analysts
Feb 2026
2 Feb · Analysts
2 Feb · Analysts
Aug 2025
7 Aug · Analysts
Jul 2025
31 Jul · Analysts
Jun 2025
16 Jun · Analysts
Feb 2025
5 Feb · Analysts
Jan 2025
27 Jan · Analysts
Oct 2024
19 Oct · Analysts
Sep 2024
11 Sep · Analysts
Aug 2024
16 Aug · Analysts
Jun 2024
12 Jun · Analysts
Mar 2024
11 Mar · Analysts
5 Mar · Analysts
May 2023
30 May · Analysts
Feb 2023
1 Feb · Analysts
Jan 2023
27 Jan · Analysts
Oct 2022
13 Oct · Analysts
Jul 2022
26 Jul · Analysts
May 2022
31 May · Analysts
20 May · Analysts
Apr 2022
Mar 2022
Jan 2022
27 Jan · Analysts
Nov 2021
15 Nov · Analysts
Oct 2021
14 Oct · Analysts
Sep 2021
23 Sep · Analysts
Aug 2021
31 Aug · Analysts
21 Aug · Analysts
16 Aug · Analysts
Jul 2021
15 Jul · Analysts
Jun 2021
23 Jun · Analysts
10 Jun · Analysts
May 2021
28 May · Analysts
Jan 2021
29 Jan · Analysts
Dec 2020
2 Dec · Analysts
Nov 2020
Oct 2020
Sep 2020
Aug 2020
28 Aug · Analysts
May 2020
Mar 2020